Retinal imaging: The eye as a window to the brain

Dr. Stephen Salloway and his team at the Butler Hospital Memory and Aging Program are conducting groundbreaking research, including the new Atlas of Retinal Imaging Study (ARIAS)—launching in the spring of 2019—to create a reference library of retinal imaging across the Alzheimer’s Disease spectrum. The team is also testing new biomarkers and medications for the prevention and early intervention for AD, including:

  • Cutting edge fluid and imaging biomarkers and novel cognitive assessments that use machine learning to study the evolution of AD pathophysiology and determine AD risk and disease stage.
  • Targeted treatments such as BACE inhibitors and monoclonal antibodies, alone and in combination, to lower amyloid plaques and neurofibrillary tangles.

Research Leads

  • Stephen Salloway

    Associate Director of Clinical Research for the Center for Alzheimer's Disease Research, Martin M. Zucker Professor of Psychiatry and Human Behavior, Professor of Neurology

    Biomarker and drug development for Alzheimer’s disease

  • Jessica Alber

  • Athene Lee

  • Peter Snyder

    Professor of Neurology, Professor of Surgery